Complementary and alternative medicine use in chronic liver disease patients

Leah M. Ferrucci, Beth P. Bell, Kathy B. Dhotre, M. Michele Manos, Norah A. Terrault, Atif Zaman, Rosemary C. Murphy, Grace R. Vanness, Ann R. Thomas, Stephanie R. Bialek, Mayur M. Desai, Andre N. Sofair

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.

Original languageEnglish (US)
JournalJournal of Clinical Gastroenterology
Volume44
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Complementary Therapies
Liver Diseases
Chronic Disease
Hepatitis C
Alcohols
Population Surveillance
Homeopathy
Herbal Medicine

Keywords

  • Chronic liver disease
  • Complementary and alternative medicine
  • Epidemiology

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Ferrucci, L. M., Bell, B. P., Dhotre, K. B., Manos, M. M., Terrault, N. A., Zaman, A., ... Sofair, A. N. (2010). Complementary and alternative medicine use in chronic liver disease patients. Journal of Clinical Gastroenterology, 44(2). https://doi.org/10.1097/MCG.0b013e3181b766ed

Complementary and alternative medicine use in chronic liver disease patients. / Ferrucci, Leah M.; Bell, Beth P.; Dhotre, Kathy B.; Manos, M. Michele; Terrault, Norah A.; Zaman, Atif; Murphy, Rosemary C.; Vanness, Grace R.; Thomas, Ann R.; Bialek, Stephanie R.; Desai, Mayur M.; Sofair, Andre N.

In: Journal of Clinical Gastroenterology, Vol. 44, No. 2, 02.2010.

Research output: Contribution to journalArticle

Ferrucci, LM, Bell, BP, Dhotre, KB, Manos, MM, Terrault, NA, Zaman, A, Murphy, RC, Vanness, GR, Thomas, AR, Bialek, SR, Desai, MM & Sofair, AN 2010, 'Complementary and alternative medicine use in chronic liver disease patients', Journal of Clinical Gastroenterology, vol. 44, no. 2. https://doi.org/10.1097/MCG.0b013e3181b766ed
Ferrucci, Leah M. ; Bell, Beth P. ; Dhotre, Kathy B. ; Manos, M. Michele ; Terrault, Norah A. ; Zaman, Atif ; Murphy, Rosemary C. ; Vanness, Grace R. ; Thomas, Ann R. ; Bialek, Stephanie R. ; Desai, Mayur M. ; Sofair, Andre N. / Complementary and alternative medicine use in chronic liver disease patients. In: Journal of Clinical Gastroenterology. 2010 ; Vol. 44, No. 2.
@article{d5eab68afb214c19ac5a8c0558eda91d,
title = "Complementary and alternative medicine use in chronic liver disease patients",
abstract = "GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3{\%}) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1{\%}) patients. This was followed by herbal medicine (175 patients, 16.8{\%}) and homeopathy (16 patients, 1.5{\%}). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.",
keywords = "Chronic liver disease, Complementary and alternative medicine, Epidemiology",
author = "Ferrucci, {Leah M.} and Bell, {Beth P.} and Dhotre, {Kathy B.} and Manos, {M. Michele} and Terrault, {Norah A.} and Atif Zaman and Murphy, {Rosemary C.} and Vanness, {Grace R.} and Thomas, {Ann R.} and Bialek, {Stephanie R.} and Desai, {Mayur M.} and Sofair, {Andre N.}",
year = "2010",
month = "2",
doi = "10.1097/MCG.0b013e3181b766ed",
language = "English (US)",
volume = "44",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Complementary and alternative medicine use in chronic liver disease patients

AU - Ferrucci, Leah M.

AU - Bell, Beth P.

AU - Dhotre, Kathy B.

AU - Manos, M. Michele

AU - Terrault, Norah A.

AU - Zaman, Atif

AU - Murphy, Rosemary C.

AU - Vanness, Grace R.

AU - Thomas, Ann R.

AU - Bialek, Stephanie R.

AU - Desai, Mayur M.

AU - Sofair, Andre N.

PY - 2010/2

Y1 - 2010/2

N2 - GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.

AB - GOALS: To examine a wide range of sociodemographic and clinical characteristics as potential predictors of complementary and alternative medicine (CAM) use among chronic liver disease (CLD) patients, with a focus on CAM therapies with the greatest potential for hepatotoxicity and interactions with conventional treatments. BACKGROUND: There is some evidence that patients with CLD commonly use CAM to address general and CLD-specific health concerns. STUDY: Patients enrolled in a population-based surveillance study of persons newly diagnosed with CLD between 1999 and 2001 were asked about current use of CAM specifically for CLD. Sociodemographic and clinical information was obtained from interviews and medical records. Predictors of CAM use were examined using univariate and multivariate logistic regression analysis. RESULTS: Of the 1040 participants, 284 (27.3%) reported current use of at least 1 of 3 CAM therapies of interest. Vitamins or other dietary supplements were the most commonly used therapy, reported by 188 (18.1%) patients. This was followed by herbal medicine (175 patients, 16.8%) and homeopathy (16 patients, 1.5%). Several characteristics were found to be independent correlates of CAM use: higher education and family income, certain CLD etiologies (alcohol, hepatitis C, hepatitis C and alcohol, and hepatitis B), and prior hospitalization for CLD. CONCLUSIONS: Use of CAM therapies that have the potential to interact with conventional treatments for CLD was quite common among this population-based sample of patients with CLD. There is a need for patient and practitioner education and communication regarding CAM use in the context of CLD.

KW - Chronic liver disease

KW - Complementary and alternative medicine

KW - Epidemiology

UR - http://www.scopus.com/inward/record.url?scp=75749140935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749140935&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e3181b766ed

DO - 10.1097/MCG.0b013e3181b766ed

M3 - Article

C2 - 19779363

AN - SCOPUS:75749140935

VL - 44

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 2

ER -